CD19 Polyclonal Antibody, APC-Cy5.5 Conjugated, APC/Cy5.5, Rabbit

Catalog Number: BSS-BS-20781R-APC-CY5.5
Article Name: CD19 Polyclonal Antibody, APC-Cy5.5 Conjugated, APC/Cy5.5, Rabbit
Biozol Catalog Number: BSS-BS-20781R-APC-CY5.5
Supplier Catalog Number: bs-20781R-APC-Cy5.5
Alternative Catalog Number: BSS-BS-20781R-APC-CY5.5-100
Manufacturer: Bioss
Host: Rabbit
Category: Antikörper
Application: FC, IF, WB
Species Reactivity: Human
Conjugation: APC/Cy5.5
Alternative Names: Antibody deficiency due to defect in CD19, included, AW495831, B lymphocyte antigen CD19, B lymphocyte surface antigen B4, B4, CD 19, CD19 antigen, CD19 molecule, Cd19 protein, Differentiation Antigen CD19, Leu 12, Leu12, Lymphocyte Surface Antigen, MGC109570, MGC12802, T-cell surface antigen Leu-12.
CD19 is a transmembrane glycoprotein that is delectively expressed on the cell surface of B-lymphocytes,where it activates intracellular signaling cascades involving both Ras and phosphatidylinositol 3-kinase pathways.Lymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. This gene encodes a cell surface molecule which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation.
Clonality: Polyclonal
Concentration: 1ug/ul
NCBI: 930
UniProt: P15391
Buffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Source: KLH conjugated synthetic peptide derived from human CD19
Target: CD19
Application Dilute: WB(1:300-5000), FCM(1:20-100), IF(ICC)(1:50-200), IF()